Assyro AI

Orange Book product · Brand (NDA)

ZEGALOGUE

DASIGLUCAGON HYDROCHLORIDE

Brand (NDA)NDA 214231DISCN ZEALAND PHARMA

At a glance

Mar 22, 2021

Approved

Brand (NDA)

Application

Not listed

TE code

2

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 22, 2021

    5 yr 4 mo ago

  2. Exclusivity ends · NCE

    New chemical entity exclusivity (5 years)

    Mar 22, 2026

    3 mo ago

  3. Today

  4. Patent 11795204 expires

    Listed method-of-use patent (U-3752) expiration.

    Jan 06, 2034

    in 7 yr 8 mo

  5. Patent 10442847 expires

    Listed drug substance patent expiration.

    Mar 22, 2035

    in 8 yr 11 mo

Pharmaceutical detail

Active ingredient

DASIGLUCAGON HYDROCHLORIDE

Strength

EQ 0.6MG BASE/0.6ML (EQ 0.6MG BASE/0.6ML)

Dosage form

SOLUTION

Route

SUBCUTANEOUS

TE code

Not listed

Application

NDA 214231

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

Yes

Reference standard (RS)

No

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • NCENew chemical entity exclusivity (5 years)

    Mar 22, 2026

    3 mo ago

Listed patents (2)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
11795204Jan 06, 2034in 7 yr 8 mo
U-3752
10442847Mar 22, 2035in 8 yr 11 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.